Purchase Order 75N95024P00336
Award Date
6/18/24
Potential Completion Date
9/18/24
Potential Value
$24K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Cellecta, Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Mountain View, CA 94043, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $96,000 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Cellecta, Inc., a for-profit manufacturer of genetic research tools. The award supports NCATS' RNAi screening facility by enabling the development of flexible functional genomics platforms that offer complementary and orthogonal CRISPR screens to NIH intramural investigators. The contract does not...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $16,000.00 firm fixed price purchase order to Cellecta, Inc. for the delivery of a "HUMAN GENOME-WIDE CRISPRI DUAL-SGRNA LIBRARY (VIRUS)". This order, which does not have a set-aside designation, will be completed by September 7, 2022. Cellecta, Inc. is a for-profit organization that specializes in providing genetic screening services, including...
This federal contract award to Cellecta, Inc., a for-profit manufacturer of genetic research tools, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH). The $16,305 firm fixed-price purchase order is for the delivery of a pooled single guide RNA (sgRNA) CRISPR-Cas9 library, which will support biomedical research initiatives. The contract did not have a small business set-aside designation. Cellecta has been a consistent...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $20,130.00 firm-fixed-price purchase order to Cellecta, Inc. (doing business as Cellecta Inc.), a for-profit organization and manufacturer of goods. The award is for the delivery of a human genome-wide CRISPR-Cas9 dual-single guide RNA (sgRNA) library (virus). This contract is not set aside for any type of small business. Cellecta has previously provided a...
This federal contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Cellecta, Inc., a for-profit manufacturer of genomic research products and services. The $299,952 firm-fixed price contract is for "GENETIC ANALYSIS OF CTCS AT THE SINGLE-CELL LEVEL" and does not have a set-aside designation. Cellecta specializes in providing advanced genomic technologies, including CRISPR, RNAi, and other tools, to support biomedical research...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Cellecta, Inc., a for-profit manufacturer of genetic research tools and services. The $13,500.00 contract is for the delivery of Cellecta's proprietary lentiviral packaging products to support biomedical research. The contract does not have a small business set-aside designation. Cellecta has consistently secured federal contracts and grants, primarily from the National...
This is a $88,310 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Synthego Corporation, a small disadvantaged business manufacturer of gene editing products. The contract is for CRISPR gene editing services to develop five different induced pluripotent stem (iPS) cell lines expressing fluorescent proteins or HiBiT tags at specific target genes. This is a non-competitive award under...
This is a $60,132.50 firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the National Institutes of Health (NIH), to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products. The contract is for the provision of a Whole Human Genome Arrayed CRISPR Screening Library to support NCATS' translational science research efforts. This award is not associated with a...
The National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), awarded a $23,940.00 firm-fixed-price purchase order to Life Technologies Corporation, a division of Thermo Fisher Scientific, for a View RNA in situ hybridization (ISH) cell assay kit. This acquisition supports NCATS' Cooperative Research and Development Agreement (CRADA) for Alagille syndrome (ALGS) research, specifically to screen compound libraries for activators of the...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,512.25 firm fixed-price purchase order to Life Technologies Corporation of Carlsbad, California. As the prime contractor, Life Technologies will provide products or services to NIH NCATS between August 31 and October 1, 2023. The award is not associated with a multiple award contract vehicle. No subcontractors or set aside designations were indicated....